Health Care & Life Sciences » Biotechnology | Actinogen Medical Ltd.

Actinogen Medical Ltd.

Actinogen Medical Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.01
Market Cap
AUD12.71 M
Shares Outstanding
1.12 B
Public Float
-

Profile

Address
109 Pitt Street
Sydney New South Wales (NSW) 2000
Australia
Employees -
Website http://www.actinogen.com.au
Updated 07/08/2019
Actinogen Medical Ltd. is a clinical stage Australian biotechnology company, which focuses on the development of novel treatments for Alzheimer's disease and other major age-related neurodegenerative disorders. The company was founded by David Keast on March 23, 1999 and is headquartered in West Perth, Australia. .

Financials

View All
Created with Highcharts 5.0.14Actinogen Medical Ltd.Net Income. Fiscal year is July-June. All values AUD Thousands.4404405 4315 4313 6333 6333 1903 1906 2306 2302014201520162017201802k4k6k8k
Created with Highcharts 5.0.14Actinogen Medical Ltd.Sales/Revenue. Fiscal year is July-June. All values AUD Thousands.202000000000201420152016201720180510152025

Geoff E. D. Brooke
Chairman
George Morstyn
Non-Executive Director